{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:40:05Z","timestamp":1751442005738,"version":"3.41.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01675-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:01:55Z","timestamp":1751439715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SHMT2 overexpression improves glaucoma by enhancing mitophagy in retinal ganglion cells through promoting the phospho of PINK1"],"prefix":"10.1186","volume":"20","author":[{"given":"Liying","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081.","journal-title":"Ophthalmology"},{"key":"1675_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: A review. JAMA: J Am Med Association. 2014;311:1901.","journal-title":"JAMA: J Am Med Association"},{"key":"1675_CR3","first-page":"225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of Glaucoma. DTSCH ARZTEBL INT. 2020;117:225.","journal-title":"DTSCH ARZTEBL INT"},{"key":"1675_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","volume":"105","author":"JM Kang","year":"2021","unstructured":"Kang JM, Tanna AP, Glaucoma. MED CLIN N AM. 2021;105:493.","journal-title":"MED CLIN N AM"},{"key":"1675_CR5","doi-asserted-by":"publisher","first-page":"102687","DOI":"10.1016\/j.redox.2023.102687","volume":"62","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, You M, Fan C, Rong R, Li H, Xia X. Pathologically high intraocular pressure induces mitochondrial dysfunction through Drp1 and leads to retinal ganglion cell PANoptosis in glaucoma. REDOX BIOL. 2023;62:102687.","journal-title":"REDOX BIOL"},{"key":"1675_CR6","doi-asserted-by":"publisher","first-page":"101988","DOI":"10.1016\/j.redox.2021.101988","volume":"43","author":"JR Tribble","year":"2021","unstructured":"Tribble JR, Otmani A, Sun S, Ellis SA, Cimaglia G, Vohra R, Joe M, Lardner E, Venkataraman AP, Dominguez-Vicent A, Kokkali E, Rho S, Johannesson G, Burgess RW, Fuerst PG, Brautaset R, Kolko M, Morgan JE, Crowston JG, Votruba M, Williams PA. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. REDOX BIOL. 2021;43:101988.","journal-title":"REDOX BIOL"},{"key":"1675_CR7","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/ijms21051882","volume":"21","author":"I Rosignol","year":"2020","unstructured":"Rosignol I, Villarejo-Zori B, Teresak P, Sierra-Filardi E, Pereiro X, Rodr\u00edguez-Muela N, Vecino E, Vieira HLA, Bell K, Boya P. The Mito -QC reporter for quantitative mitophagy assessment in primary retinal ganglion cells and experimental Glaucoma models. Int J Mol Sci. 2020;21:1882.","journal-title":"Int J Mol Sci"},{"key":"1675_CR8","doi-asserted-by":"crossref","unstructured":"Stavropoulos D, Grewal MK, Petriti B, Chau KY, Hammond CJ, Garway-Heath DF, Lascaratos G. The role of mitophagy in glaucomatous neurodegeneration. CELLS-BASEL 2023;12.","DOI":"10.3390\/cells12151969"},{"key":"1675_CR9","doi-asserted-by":"publisher","first-page":"e104705","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021;40:e104705.","journal-title":"EMBO J"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41419-017-0146-9","volume":"9","author":"Y Dai","year":"2018","unstructured":"Dai Y, Hu X, Sun X. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma. CELL DEATH DIS. 2018;9:10.","journal-title":"CELL DEATH DIS"},{"key":"1675_CR11","first-page":"3582","volume":"39","author":"DT Hass","year":"2019","unstructured":"Hass DT, Barnstable CJ. Mitochondrial uncoupling protein 2 Knock-out promotes mitophagy to decrease retinal ganglion cell death in a mouse model of Glaucoma. J Neurosci. 2019;39:3582.","journal-title":"J Neurosci"},{"key":"1675_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fnmol.2018.00350","volume":"11","author":"X Hu","year":"2018","unstructured":"Hu X, Dai Y, Zhang R, Shang K, Sun X. Overexpression of optic atrophy type 1 protects retinal ganglion cells and upregulates parkin expression in experimental Glaucoma. FRONT MOL NEUROSCI. 2018;11:350.","journal-title":"FRONT MOL NEUROSCI"},{"key":"1675_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2018.01.024","volume":"69","author":"DR Minton","year":"2018","unstructured":"Minton DR, Nam M, McLaughlin DJ, Shin J, Bayraktar EC, Alvarez SW, Sviderskiy VO, Papagiannakopoulos T, Sabatini DM, Birsoy K, Possemato R. Serine catabolism by SHMT2 is required for proper mitochondrial translation initiation and maintenance of Formylmethionyl-tRNAs. MOL CELL. 2018;69:610.","journal-title":"MOL CELL"},{"key":"1675_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/blood.2021012081","volume":"139","author":"AC Wilke","year":"2022","unstructured":"Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, Comoglio F, Phelan JD, Wang JQ, Pikman Y, Jahn D, Haupl B, Schneider C, Scheich S, Tosto FA, Bohnenberger H, Stauder P, Schnutgen F, Slabicki M, Coulibaly ZA, Wolf S, Bojarczuk K, Chapuy B, Brandts CH, Stroebel P, Lewis CA, Engelke M, Xu X, Kim H, Dang TH, Schmitz R, Hodson DJ, Stegmaier K, Urlaub H, Serve H, Schmitt CA, Kreuz F, Knittel G, Rabinowitz JD, Reinhardt HC, Vander HM, Thomas C, Staudt LM, Zenz T, Oellerich T. SHMT2 Inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. 2022;139:538.","journal-title":"Blood"},{"key":"1675_CR15","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.7150\/thno.48699","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu C, Wang L, Liu X, Tan Y, Tao L, Xiao Y, Deng P, Wang H, Deng Q, Lin Y, Jie H, Zhang H, Zhang J, Peng Y, Zhang H, Zhou Z, Sun Q, Cen X, Zhao Y. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting beta-catenin degradation. THERANOSTICS. 2021;11:2966.","journal-title":"THERANOSTICS"},{"key":"1675_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-024-06476-1","volume":"15","author":"M Sun","year":"2024","unstructured":"Sun M, Zhao M, Li R, Zhang Y, Shi X, Ding C, Ma C, Lu J, Yue X. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. CELL DEATH DIS. 2024;15:87.","journal-title":"CELL DEATH DIS"},{"key":"1675_CR17","doi-asserted-by":"crossref","unstructured":"Schmelter C, Fomo KN, Perumal N, Pfeiffer N, Grus FH. Regulation of the HTRA2 protease activity by an inhibitory Antibody-Derived peptide ligand and the influence on HTRA2-Specific protein interaction networks in retinal tissues. BIOMEDICINES 2021;9.","DOI":"10.3390\/biomedicines9081013"},{"key":"1675_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41419-023-05713-3","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Fan M, Hou J, Pan S, Xu Y, Zhang H, Liu C, Hao X, Li X, Wang H. Correction: Serine hydroxymethyltransferase 2 knockdown induces apoptosis in CcRCC by causing lysosomal membrane permeabilization via metabolic reprogramming. CELL DEATH DIS. 2023;14:180.","journal-title":"CELL DEATH DIS"},{"key":"1675_CR19","first-page":"18","volume":"63","author":"P Lu","year":"2022","unstructured":"Lu P, Shi Y, Ye D, Lu X, Tang X, Cheng L, Xu Y, Huang J. Intravitreal injection of PACAP attenuates acute ocular Hypertension-Induced retinal injury via Anti-Apoptosis and Anti-Inflammation in mice. INVEST OPHTH VIS SCI. 2022;63:18.","journal-title":"INVEST OPHTH VIS SCI"},{"key":"1675_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. CELL DEATH DIFFER. 2013;20:31.","journal-title":"CELL DEATH DIFFER"},{"key":"1675_CR21","doi-asserted-by":"crossref","unstructured":"Zhuang D, Zhang R, Liu H, Dai Y. A small natural molecule S3 protects retinal ganglion cells and promotes Parkin-Mediated mitophagy against excitotoxicity. MOLECULES 2022;27.","DOI":"10.3390\/molecules27154957"},{"key":"1675_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-023-02855-1","volume":"20","author":"M Wei","year":"2023","unstructured":"Wei M, Zhang G, Huang Z, Ding X, Sun Q, Zhang Y, Zhu R, Guan H, Ji M. ATP-P2X7R-mediated microglia senescence aggravates retinal ganglion cell injury in chronic ocular hypertension. J NEUROINFLAMM. 2023;20:1.","journal-title":"J NEUROINFLAMM"},{"key":"1675_CR23","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","volume":"4","author":"J Ye","year":"2014","unstructured":"Ye J, Fan J, Venneti S, Wan Y, Pawel BR, Zhang J, Finley LWS, Lu C, Lindsten T, Cross JR, Qing G, Liu Z, Simon MC, Rabinowitz JD, Thompson CB. Serine catabolism regulates mitochondrial redox control during hypoxia. CANCER DISCOV. 2014;4:1406.","journal-title":"CANCER DISCOV"},{"key":"1675_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00401-020-02223-w","volume":"140","author":"A Garcia-Cazorla","year":"2020","unstructured":"Garcia-Cazorla A, Verdura E, Julia-Palacios N, Anderson EN, Goicoechea L, Planas-Serra L, Tsogtbaatar E, Dsouza NR, Schluter A, Urreizti R, Tarnowski JM, Gavrilova RH, Ruiz M, Rodriguez-Palmero A, Fourcade S, Cogne B, Besnard T, Vincent M, Bezieau S, Folmes CD, Zimmermann MT, Klee EW, Pandey UB, Artuch R, Cousin MA, Pujol A. Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome. ACTA NEUROPATHOL. 2020;140:971.","journal-title":"ACTA NEUROPATHOL"},{"key":"1675_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","volume":"19","author":"L Su","year":"2023","unstructured":"Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. AUTOPHAGY. 2023;19:401.","journal-title":"AUTOPHAGY"},{"key":"1675_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","volume":"19","author":"R Han","year":"2023","unstructured":"Han R, Liu Y, Li S, Li XJ, Yang W. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. AUTOPHAGY. 2023;19:1396.","journal-title":"AUTOPHAGY"},{"key":"1675_CR27","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L. CDK9 Inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. AUTOPHAGY. 2022;18:1879.","journal-title":"AUTOPHAGY"},{"key":"1675_CR28","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1080\/15548627.2021.1917129","volume":"17","author":"MW El","year":"2021","unstructured":"El MW, Duplan E, Goiran T, Lauritzen I, Vaillant BL, Lacas-Gervais S, Morais VA, You H, Qi L, Salazar M, Ozcan U, Chami M, Checler F, Alves DCC. Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology. AUTOPHAGY. 2021;17:4363.","journal-title":"AUTOPHAGY"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01675-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:01:56Z","timestamp":1751439716000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01675-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01675-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai Xinshijie Dongqu Eye Hospital. This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. All animal experiments should comply with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}